https://newsletter.pharmamkt.net/2019/12/02/seattle-genetics-and-astellas-announce-clinical-trial-collaboration-with-merck-to-evaluate-enfortumab-vedotin-in-combination-with-keytruda-pembrolizumab-in-patients-with-metastatic-urothelial/